OXGF(300082)
Search documents
奥克股份:公司医药级聚乙二醇产品主要用作医药辅料及原料药
Zheng Quan Ri Bao Wang· 2025-08-04 10:41
Core Viewpoint - The company, Aoke Co., Ltd. (300082), clarified that its pharmaceutical-grade polyethylene glycol products are primarily used as pharmaceutical excipients and raw materials, and do not directly participate in innovative drug development [1] Company Summary - Aoke Co., Ltd. has confirmed that its products serve as pharmaceutical excipients and raw materials [1] - The company has disclosed relevant information regarding its operations in regular reports [1]
奥克股份:公司信息披露严格遵循监管规定履行披露义务
Zheng Quan Ri Bao Zhi Sheng· 2025-07-31 12:41
(编辑 袁冠琳) 证券日报网讯 奥克股份7月31日在互动平台回答投资者提问时表示,技术创新和产品研发不可能一蹴而 就,公司信息披露严格遵循监管规定履行披露义务。董事会始终依法履行职责,聚焦公司发展战略,推 动各项业务有序开展。 ...
奥克股份:与科之杰等减水剂生产企业建立了战略合作伙伴关系
Zheng Quan Ri Bao Wang· 2025-07-31 12:12
证券日报网讯奥克股份(300082)7月31日在互动平台回答投资者提问时表示,公司与科之杰、苏博特 (603916)、东方雨虹(002271)、西卡等知名减水剂生产企业建立了战略合作伙伴关系,在定期报告 中已有披露。 ...
奥克股份:全资孙公司主要销售减水剂聚醚单体等环氧乙烷精细化工产业链产品
Zheng Quan Ri Bao· 2025-07-31 11:45
Core Viewpoint - The company, Aoke Co., Ltd., has confirmed through an interactive platform that its wholly-owned subsidiary, Tibet Aoke Chemical Sales Co., Ltd., primarily sells water-reducing agents and polyether monomers, which are products in the fine chemical industry chain of ethylene oxide [2] Company Summary - Aoke Co., Ltd. operates in the fine chemical industry, focusing on products derived from ethylene oxide [2] - The company's subsidiary, Tibet Aoke Chemical Sales Co., Ltd., is engaged in the sales of specific chemical products, including water-reducing agents and polyether monomers [2]
奥克股份:公司高度重视国家重大水利工程带来的战略机遇
Zheng Quan Ri Bao Zhi Sheng· 2025-07-31 11:40
(编辑 王雪儿) 证券日报网讯 奥克股份7月31日在互动平台回答投资者提问时表示,公司高度重视国家重大水利工程带 来的战略机遇,密切关注政策动态及行业发展趋势,结合行业及自身实际情况,积极开展跟踪与研究。 ...
奥克股份:董事会聚焦发展战略推动各项业务有序开展
Jin Rong Jie· 2025-07-31 04:50
Core Viewpoint - The company has not disclosed any progress on the high-end applications of polyethylene glycol, leading to investor concerns about the board's effectiveness and the company's innovation capabilities [1] Group 1 - The company responded to investor inquiries by emphasizing that technological innovation and product development take time and cannot be rushed [1] - The company stated that it strictly adheres to regulatory disclosure requirements and fulfills its obligations accordingly [1] - The board is focused on the company's development strategy and is working to advance various business operations in an orderly manner [1]
奥克股份:全资子公司海南奥克目前享受海南省15%企业所得税优惠税率等政府优惠政策
Zheng Quan Ri Bao Wang· 2025-07-30 09:22
证券日报网讯 奥克股份(300082)7月30日在互动平台回答投资者提问时表示,公司全资子公司海南奥 克目前享受海南省15%企业所得税优惠税率、出口退税、绿色工厂补贴、用电补贴等政府优惠政策。 ...
奥克股份:药用聚乙二醇产品主要作为药用辅料和原料药使用
Zheng Quan Ri Bao Wang· 2025-07-30 09:17
证券日报网讯奥克股份(300082)7月30日在互动平台回答投资者提问时表示,公司药用聚乙二醇产品 主要作为药用辅料和原料药使用,下游客户众多,公司不完全掌握下游客户的具体应用场景。若有依法 需要披露的信息,公司将严格按照法律法规履行信息披露义务。 ...
奥克股份:公司持续密切关注国家政策动态和发展机遇
Zheng Quan Ri Bao Wang· 2025-07-30 09:13
Group 1 - The company, Aoke Co., Ltd. (300082), is closely monitoring national policy dynamics and development opportunities [1] - The focus is particularly on areas related to the company's main business in construction chemicals [1]
奥克股份:产品减水剂聚醚单体在国内市场份额处于行业头部地位
Zheng Quan Ri Bao Wang· 2025-07-30 09:13
Group 1 - The company, Aoke Co., Ltd. (300082), holds a leading market share in the domestic market for water-reducing agents, specifically polyether monomers [1] - Subote (603916) is a downstream customer of the company's polyether monomer products, and both companies maintain a stable and ongoing cooperative relationship [1] - The company places significant emphasis on the strategic opportunities presented by major national water conservancy projects and closely monitors policy dynamics and industry development trends [1]